KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Total Current Liabilities (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Total Current Liabilities for 15 consecutive years, with $139.1 million as the latest value for Q4 2024.

  • On a quarterly basis, Total Current Liabilities rose 23.65% to $139.1 million in Q4 2024 year-over-year; TTM through Dec 2024 was $139.1 million, a 23.65% increase, with the full-year FY2024 number at $139.1 million, up 23.65% from a year prior.
  • Total Current Liabilities was $139.1 million for Q4 2024 at Halozyme Therapeutics, up from $108.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $421.4 million in Q4 2020 to a low of $91.9 million in Q1 2023.
  • A 5-year average of $150.9 million and a median of $114.3 million in 2021 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 392.06% in 2020, then plummeted 72.2% in 2021.
  • Halozyme Therapeutics' Total Current Liabilities stood at $421.4 million in 2020, then tumbled by 72.2% to $117.1 million in 2021, then rose by 11.65% to $130.8 million in 2022, then fell by 13.99% to $112.5 million in 2023, then increased by 23.65% to $139.1 million in 2024.
  • Per Business Quant, the three most recent readings for HALO's Total Current Liabilities are $139.1 million (Q4 2024), $108.8 million (Q3 2024), and $112.5 million (Q4 2023).